00
Days
00
Hours
00
Minutes
00
Seconds

45th Annual Meeting

Annual Meeting Theme:
It Takes a Village: Patient Centered Partnerships in Clinical Trials

When

May 19-22, 2024

Where

Boston, MA, USA

Registration

Now Open!

The Conference Venue

Boston Marriott Copley Place

Explore family-friendly amenities and some of America's most treasured attractions when you stay at Boston Marriott Copley Place. Our premium hotel offers deluxe amenities, a new lobby experience, exclusive M Club lounge, and comfortable rooms for a great night's sleep, all in the heart of Boston's vibrant Back Bay neighborhood.

Beyond Back Bay, experience the many unique neighborhoods that make up this historic city, from cozy Italian restaurants in the North End to the entertainment and vibrant nightlife of the Theater District.

Meeting | Overview

About the Annual Meeting
The Annual Meeting of the Society for Clinical Trials is a multidisciplinary program with broad participation. The Meeting brings together the clinical trials community from academia, the pharmaceutical and device industries, government agencies, medical groups and centers and clinical research entities.

Highlights include:

  • Cutting edge pre-conference workshops by leaders in the field (Pre-Conference Workshop 8: Essentials of Clinical Trials is only available to first-time attendees, students, and post-graduates. First-time attendees, students, and post-graduates interested in registering for this complimentary workshop must be registered for the general meeting. If you are a first-time attendee, have registered for the general meeting and would like to register for Pre-Conference Workshop 8: Essentials of Clinical Trials, we ask that you please email registration@sctweb.org to register for this workshop.)
  • Invited sessions, targeted sessions, contributed sessions, and poster presentations
  • Founders and Curtis Meinert Keynote Lectures
  • Annual Thomas C. Chalmers Student Scholarship competition
  • Presentation by the Sylvan Green Award winner
  • Exhibitors showcasing publications, technology innovators and other resources for clinical trials
  • Discussions of timely issues and research experiences among colleagues in the field
  • Presentation of the SCT Class of 2024 Fellows
  • Presentation of the 2023 David Sackett Trial of the Year Award
  • Roundtable small group discussions on a wide range of topics
  • Networking with your colleagues

This year’s meeting will be Boston, MA, USA.

The program is being developed by the SCT Program, Education, and Student Scholarship Committees, and promises to make the best of this unique opportunity for global collaboration.

We look forward to welcoming you!


About the Society
The Society for Clinical Trials (SCT) is an educational, charitable, and scientific organization whose mission is to work internationally to advance human health through advocating the use of clinical trials, leading the development and dissemination of optimal methods and practices in clinical trials, and educating and developing all clinical trial professionals. We are a society with representation from academia, industry, government and non-profit research and advocacy groups. Our community consists of clinical investigators, biostatisticians, project managers, IT specialists, clinical research associates and people from other clinical trials specialties. Our membership spans the globe with representation from 34 different countries.

Find out more: http://www.sctweb.org/

Category Member Student Member Non-Member Student Non-Member
Meeting Registration
   (Early-Bird By March 25)
   (March 26 - April 29)
   (After April 29)

$725.00
$825.00
$925.00

$250.00
$250.00
$250.00

$995.00
$1095.00
$1195.00

$350.00
$350.00
$350.00
Pre-Conference Workshops Half-day
   (Sunday)
Pre-Conference Workshop 8: Essentials
of Clinical Trials - Only available to first-time
attendees, students, and post-graduates.
Complimentary. Must be registered for
the general meeting.

$250.00

$250.00

$250.00

$250.00
Roundtables (Monday 12:30-1:45) $0.00 $0.00 $0.00 $0.00
Guest Registration Fee
(FOR NETWORKING WELCOME RECEPTION
MONDAY, MAY 20, 5:30 PM - 7:00 PM)
$100.00 $100.00 $100.00 $100.00
  • Pre-Conference Workshops
    Pre-Conference Workshop 8: Essentials of Clinical Trials is only available to first-time attendees, students, and post-graduates. First-time attendees, students, and post-graduates interested in registering for this complimentary workshop must be registered for the general meeting. If you are a first-time attendee, have registered for the general meeting and would like to register for Pre-Conference Workshop 8: Essentials of Clinical Trials, we ask that you please email registration@sctweb.org to register for this workshop.
  • Roundtables
    Join a moderator led, small group, informal discussion over lunch on a topic you would like to learn more about or have experiences to share. Space is limited.
  • Discounted Fees
    Discounted fee available for attendees from developing countries. Important Note: Discounted fees are only applicable to those who currently reside in one of the listed developing countries. Discounted fees are not based on country of origin. Please email registration@sctweb.org for more information about discounts or any other questions.
  • Registration Policy
    All payments must be made in USD ($) to ensure that the full amount is received. Entry to the conference will not be permitted unless full payment has been received.
  • Cancellation Policy
    Written cancellations received via email to registration@sctweb.org by May 13th will be refunded less a $75 administrative fee. There will be no refunds issued after May 13th. Failure to attend without notice will not result in a refund.
  • Video & Photography
    By attending the meeting, attendees consent to being filmed and/or photographed for SCT purposes.

Conference | Venue

Hotel Accommodations

The SCT Annual Meeting will take place at the Boston Marriott Copley Place Hotel.

BOSTON MARRIOTT COPLEY PLACE HOTEL
110 Huntington Avenue
Boston, MA 02116

Hotel Room Rates: $299 / night + 16.45% tax

Register Online:
For best availability, make your reservation at https://book.passkey.com/e/50729529

Register by Phone: 1-877-901-2079 (ask for the SCT Annual Meeting)

The deadline for hotel reservations is Wednesday, April 17, 2024.

Hotel reservations / rate availability are not guaranteed after the room block is full or after Wednesday, April 17, 2024. Please register early, only a limited number of rooms are available.

Program | At a Glance

We are delighted to release the provisional program for the 45th annual meeting of the Society which will run May 19-22, 2024. The theme for the 45th Annual Meeting is "It Takes a Village: Patient Centered Partnerships in Clinical Trials". The Program includes exciting keynote lectures, cutting edge workshops, invited sessions, contributed sessions, and poster presentations on diverse topics. Contributors come from a wide range of backgrounds and disciplines representing the range of stakeholders in clinical trial research and conduct. Clicking on the icons will download session details where available. Please note that the program is not fully confirmed and speakers and timing particularly within individual sessions may be subject to some change. Note all times are Eastern.
Sunday, May 19, 2024
7:00 AM - 5:00 PM
  • REGISTRATION Grand Ballroom Registration Desk (4th Floor)
8:00 AM - 12:00 PM
9:45 AM - 10:15 AM
  • BREAK Grand Salons H-K & Suffolk (4th Floor & 3rd Floor)
12:00 PM - 1:00 PM
  • LUNCH (ON YOUR OWN)
1:00 PM - 3:00 PM
  • PRE-CONFERENCE WORKSHOP 7 Grand Salons JK (4th Floor)
       Strategies for Integrating Health Literacy and the Participant Voice into Clinical Research Studies
1:00 PM - 5:00 PM
2:45 PM - 3:15 PM
  • BREAK Grand Salons H-K & Suffolk (4th Floor & 3rd Floor)
5:00 PM - 6:30 PM
  • BOARD OF DIRECTORS MEETING (BY INVITATION ONLY) Provincetown (4th Floor)
6:30 PM - 8:00 PM
  • FELLOWS RECEPTION
    Fellows Reception in Regis (3rd Floor)
Monday, May 20, 2024
7:30 AM - 5:00 PM
  • REGISTRATION Grand Ballroom Registration Desk (4th Floor)
8:30 AM - 8:45 AM
  • SCT PRESIDENT WELCOME Grand Salons FG (4th Floor)
    Dixie Ecklund
8:45 AM - 9:00 AM
  • PRESENTATION OF FELLOWS CLASS Grand Salons FG (4th Floor)
9:00 AM - 10:00 AM
  • TRIAL OF THE YEAR Grand Salons FG (4th Floor)
    Trial of the Year Session
10:00 AM - 10:45 AM
10:45 AM - 12:15 PM
  • INVITED SESSION 1 Grand Salons JK (4th Floor)
      Controversial Issues in Behavioral Trial Methodology
  • INVITED SESSION 2 Wellesley (3rd Floor)
      Recent development of advanced randomization designs – A progress report from the Randomization Working Group
  • INVITED SESSION 3 Grand Salons HI (4th Floor)
      Engagement and Participation of Patient Advisors with Lived Experiences in the HOPE Consortium Clinical trial to reduce Pain and Opioid Use in Hemodialysis– from inception through dissemination
  • INVITED SESSION 4 Suffolk (3rd Floor)
      Fully Remote Clinical Trials – Design, Implementation, and Challenges
  • INVITED SESSION 5 Grand Salons FG (4th Floor)
      Platform Trials: Experience in Design, Conduct, and Interpretation for NIH and Foundation Partnered Clinical Trial Networks
  • TARGETED SESSION 1 Arlington-Clarendon (3rd Floor)
      Breaking Through - Navigating the New Horizons of Patient-Partnered Clinical Trials Through the Expertise of Clinical Research Nursing
12:30 PM - 1:45 PM 2024 Roundtable Topics and Moderators
  • ROUNDTABLE 1 Grand Salons FG (4th Floor)
    Academic and Industry CROs: What are the Differences?
  • ROUNDTABLE 2
    Active Learning in the Clinical Trials Classroom
  • ROUNDTABLE 3
    Addressing the Operational Challenges in Conducting Investigator-Initiated Trials (IITs)
  • ROUNDTABLE 4
    An Introduction to the Society of Clinical Trials (SCT) and Leadership Roles in the Society
  • ROUNDTABLE 5
    Bayesian adaptive design of phase 1 dose-finding trials
  • ROUNDTABLE 6
    Budgeting for Multi-Site Clinical Trials: Factors and Considerations
  • ROUNDTABLE 7
    Career Advancement for Women and Gender Minorities Working in Clinical Trials
  • ROUNDTABLE 8
    Career Paths in Clinical Trials- Opportunities For Nurses
  • ROUNDTABLE 9
    Cluster-Randomized Crossover Trials (CRXO): Design and Analysis Features
  • ROUNDTABLE 10
    Data management career development and career paths in clinical trials
  • ROUNDTABLE 11
    Design and Analysis of Clinical Trials with Real World Data for Decision-Making
  • ROUNDTABLE 12
    Harnessing Real-World Data for Enhanced Drug Development
  • ROUNDTABLE 13 Grand Salons FG (4th Floor)
    How to Use PCORnet® for Your Next Study: A “Quick Start” Guide
  • ROUNDTABLE 14 Grand Salons FG (4th Floor)
    Implementation of complex clinical trials
  • ROUNDTABLE 15 Grand Salons FG (4th Floor)
    Implementing Patient-Centered Research in Industry Sponsored Trials: Facilitators, Barriers, and Lessons Learned
  • ROUNDTABLE 16 Grand Salons FG (4th Floor)
    Introducing Undergraduates to Clinical Trials
  • ROUNDTABLE 17 Grand Salons FG (4th Floor)
    Job-hunting Lessons Learned During the Biotech Market Correction
  • ROUNDTABLE 18 Grand Salons FG (4th Floor)
    Opportunities for Students in Clinical Trials (Student-Led)
  • ROUNDTABLE 19 Grand Salons FG (4th Floor)
    Recent developments and challenges in early phase trial design in oncology
  • ROUNDTABLE 20 Grand Salons FG (4th Floor)
    Risk-Based Monitoring
  • ROUNDTABLE 21 Grand Salons FG (4th Floor)
    Source and central data monitoring in a data coordinating center
  • ROUNDTABLE 22 Grand Salons FG (4th Floor)
    Undertaking impactful patient and public involvement (PPI) for statistical trial methodology research
  • ROUNDTABLE 23 Grand Salons FG (4th Floor)
    Utilizing Interinstitutional Partnerships to Improve Veteran Access to Clinical Research and Foster Research Collaboration across Aligned Healthcare Systems
  • ROUNDTABLE 24 Grand Salons FG (4th Floor)
    The Hidden Challenges of 3rd Party Tools in Clinical Trials
  • ROUNDTABLE 25 Grand Salons FG (4th Floor)
    An Overview of Programming of Adjudication Systems
  • ROUNDTABLE 26 Grand Salons FG (4th Floor)
    Transitioning from a Clinical Trial to an Observational Study
  • ROUNDTABLE 27 Grand Salons FG (4th Floor)
    A Discussion on Programming of EDC Websites and Related Systems
  • ROUNDTABLE 28 Grand Salons FG (4th Floor)
    From Conception to Citation: Managing Presentations and Publications in Research
  • ROUNDTABLE 29 Grand Salons FG (4th Floor)
    Utilizing the Electronic Health Record and REDCap for Participant Recruitment and Screening
  • ROUNDTABLE 30 Grand Salons FG (4th Floor)
    An Overview of WakeSHARE Platform
2:00 PM - 3:30 PM
  • INVITED SESSION 6 Wellesley (3rd Floor)
      Utilizing Technology and Statistical Methods to Amplify Patient-Centric Research in Personalized N-of-1 Trials for Behavioral Health Interventions
  • INVITED SESSION 7 Suffolk (3rd Floor)
      Novel Methods to Address Treatment Effect Heterogeneity in Cluster Randomized Trials
  • INVITED SESSION 8 Grand Salons FG (4th Floor)
      How to Address Diversity in Clinical Trial Participation
  • INVITED SESSION 9 Grand Salons JK (4th Floor)
      Lessons from the village: conducting an mpox treatment trial in remote regions of the Democratic Republic of Congo
  • INVITED SESSION 10 Arlington-Clarendon (3rd Floor)
      Design and Implementation of a Master Observational Trial:
      Early insights from the Cohort network for Adolescents and Youth with Mental Health Multimorbidity (CALM) study
  • TARGETED SESSION 2 Grand Salons HI (4th Floor)
      Patient-Centric Clinical Trials based on Benefit-risk: An Open DOOR
3:30 PM - 4:15 PM
4:15 PM - 5:15 PM
  • CONTRIBUTED SESSION 1 Grand Salons JK (4th Floor)
    Contributed Session 1: Adaptive Design and Analysis (Moderated by: Jose-Miguel Yamal)
      Covariate-adjusted Group Sequential Comparisons of Survival Probabilities
      Enhancing the Efficiency of Adaptive Platform Trials Through the Exploration of Alternative Treatment Ranking Methods
      Dynamic Surrogate-Primary Replacement Algorithm for Responsive-adaptive Randomization
      Navigating Challenges in RCT Conduct:
      A Bayesian Adaptive Semiparametric Approach Handling Primary and Secondary Endpoints in Pediatric Trial Design
  • CONTRIBUTED SESSION 2 Grand Salons HI (4th Floor)
    Contributed Session 2: Trial Design: Participant Selection (Moderated by: Dikla Blumberg)
      Transforming Healthcare Outcomes: Machine Learning-Driven Patient Selection for Improved QALY and ICER in Clinical Trials
      Assembling a cohort of at-risk participants for therapeutic clinical trials aimed at Parkinson’s disease (PD) prevention
      Mind the Gap: To What Extent Are Machine Learning and Artificial Intelligence Transforming Conventional Practices in Clinical Trial Design?
      Designing Cancer Screening Trials for Reduction in Late-stage Cancer Incidence
  • CONTRIBUTED SESSION 3 Grand Salons FG (4th Floor)
    Contributed Session 3: Data Management: Integration (Moderated by: Logan Williams)
      Efficient Clinical Supply Systems Design for Master Protocols: An Integrated Systems Approach
      A New Approach for Managing and Analyzing Near Real-Time Data Streams in the International Multicenter CRICKET (Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation) Study
      Dynamic Integration of External Source Data with CRF Data in Clinical Trial EDC System
      The Practicalities of Merging Data in a Multi-Centre, International Trial
  • CONTRIBUTED SESSION 4 Suffolk (3rd Floor)
    Contributed Session 4: Statistics: Dose-Finding (Moderated by: John VanBuren)
      Implementing and assessing Bayesian response-adaptive randomisation for backfilling in dose-finding trials
      Bayesian Random-effects Meta-analysis Using Spike-and-slab Priors for Dose Optimization
      Statistical Methods and Data Visualisation of Patient-Reported Outcomes in Early Phase Dose-Finding Oncology Trials: a Methodological Review
      Embracing Excellence in Early Phase Dose-finding Trials with SPIRIT and CONSORT Dose-finding Extension (DEFINE) Guidance
  • CONTRIBUTED SESSION 5 Arlington-Clarendon (3rd Floor)
    Contributed Session 5: Participant Perspectives and Preferences (Moderated by: Emily Rives)
      Automating patient reported outcome administration according to participant preference
      Participant-centred perspectives on trial retention
      Patient-centered outcomes and research success: case studies and lessons learned.
      From feasibility to pivotal trial– leveraging patient-centered approaches
  • CONTRIBUTED SESSION 6 Wellesley (3rd Floor)
    Contributed Session 6: Quality and Compliance (Moderated by: Cristina Murray-Krezan)
      Development and Management of an Electronic Trial Master File for an Adaptive Platform Trial
      Methods for Ensuring Data Quality of Cognitive Assessments in a Multi-Site Lifestyle Intervention Trial (U.S. POINTER)
      The Record of Study Consultation (RSC):
      Application, Maintenance, and Lessons Learned from Implementing a Clinical Trial Process Improvement System to Streamline Sponsor Guidance

      The importance of process evaluations in trials of surgical procedures and devices
5:30 PM - 7:00 PM
  • NETWORKING WELCOME RECEPTION
    Networking Welcome Reception in Gloucester (3rd Floor)
Tuesday, May 21, 2024
8:00 AM - 5:00 PM
  • REGISTRATION Grand Ballroom Registration Desk (4th Floor)
8:30 AM - 9:30 AM
  • FOUNDERS KEYNOTE LECTURE Grand Salons FG (4th Floor)
    Perspective of Those with Lived Experience: Involving a Patient in Clinical Trials | Penney Cowan
9:30 AM - 10:15 AM
10:15 AM - 11:15 AM
  • CONTRIBUTED SESSION 7 Wellesley (3rd Floor)
    Contributed Session 7: Adaptive Design and Early Stage (Moderated by : John VanBuren)
      Upstrapping to Determine Futility: Predicting Future Outcomes Nonparametrically from Past Data
      Evaluating the impact of outcome delay on the efficiency of Multi-arm Multi-stage (MAMS) trial design
      Statistical operating characteristics of Multi-arm Multi-stage (MAMS) trial for designing a seamless phase 2-3 study
      Are Safety Lead-In Phase II Clinical Trials Really Safe?
  • CONTRIBUTED SESSION 8 Grand Salons FG (4th Floor)
    Contributed Session 8: Trial Management: Centralized and Decentralized (Moderated by: Yves Rosenberg)
      Innovating Oncology Clinical Trials: A Leap towards Fully Decentralized Trials in Japan
      Centralized Recruitment and In-Home Enrollment: Lessons Learned from the Approach and Conduct of the VA CSP#2004 (MATCH) Study.
      Decentralized Investigator Initiated Clinical Trial Operations: Lessons Learned from the PaxLC Study
      Polaris, Trial within a Cohort (TWIC): Navigating complex trial setup with multiple elements including international collaboration
  • CONTRIBUTED SESSION 9 Suffolk (3rd Floor)
    Contributed Session 9: Statistics: Borrowing and Basket Designs (Moderated by: Sharon Yeatts)
      Hierarchical testing in medical device confirmatory trials involving information borrowing design with continuous monitoring
      Generalized two-stage randomized basket designs: applications to precision medicine trials
      Clinical trial designs borrowing information across patient subgroups based on fusion-penalized regression models
      Developing a Bayesian dynamic borrowing hierarchical design to impute missing baseline covariates in various Stroke trials
  • CONTRIBUTED SESSION 10 Arlington-Clarendon (3rd Floor)
    Contributed Session 10: Stakeholder Engagement and Partnership (Moderated by: Cory Goldstein)
      Equality, Diversity and Inclusion in the UPTURN study: a Blueprint for Embedding Inclusive Practices in a Clinical Trial
      Engaging Advocacy Groups in Clinical Trials:
      Development and Implementation of Parent Advisory Groups for Studies Enrolling Individuals with Congenital Heart Disease

      Champions and Advocates: Reflections on Working with a Community Leader to Develop Video Communications About Clinical Trials
      Informative, Ethical and Efficient: Collaborative Development of Recommendations to Strengthen Good Clinical Practice (GCP) Guidelines
  • CONTRIBUTED SESSION 11 Grand Salons HI (4th Floor)
    Contributed Session 11: Statistics: Beyond ITT and Missing Data (Moderated by: Charity Patterson)
      A Bayesian approach for estimating the survivor average causal effect when outcomes are truncated by death in cluster-randomized trials
      Propensity score weighted multi-source exchangeability models for incorporating external control data in randomized clinical trials
      How are the statistical methods currently used to analyse clinical trial data affected by the presence of informative dropouts? A patient level simulation in end stage kidney disease.
      Beyond Intention-to-Treat: Estimating the per-protocol effect of cocoa flavanol supplementation on cardiovascular events in the COSMOS trial
  • CONTRIBUTED SESSION 12 Grand Salons JK (4th Floor)
    Contributed Session 12: Survival Analysis (Moderated by: Audrey Mauguen)
      Defining Censoring Time in Trials with Variable Follow-Up – lessons learned from the ARCADIA Clinical Trial
      Re-interpretation of the COSMOS trial results using a Bayesian approach
      Approaches for Estimating Dynamic Treatment Regimens Embedded in Trials with Sequential Multiple Assignment:
      A Re-analysis of a Trial in Patients with Hematological Diseases

      Assessing the Impact of Informative Censoring on the Analysis of Disease-Free Survival in Adjuvant Breast Cancer Clinical Trials
11:45 AM - 12:45 PM
  • SCT BUSINESS MEETING Grand Salons FG (4th Floor)
1:00 PM - 2:30 PM
  • INVITED SESSION 11 Arlington-Clarendon (3rd Floor)
      Adaptive Designs 2.0: Making complex clinical trials more patient-centric and more efficient
  • INVITED SESSION 12 Wellesley (3rd Floor)
      Time-To-Event Analysis in Randomized Clinical Trials with Recurrent Events
  • INVITED SESSION 13 Grand Salons FG (4th Floor)
      Strategies to Expedite Improvements in Equity, Diversity, and Inclusion in Clinical Trials Participation
  • INVITED SESSION 14 Suffolk (3rd Floor)
      Assessing the Quality of Real-World Data for Regulatory Purposes in the Rare Disease Setting
  • INVITED SESSION 15 Grand Salons HI (4th Floor)
      Establishing a Clinical Trials Platform to Support Pragmatic Trials for VHA Dialysis Patients
  • TARGETED SESSION 3 Grand Salons JK (4th Floor)
      Catching up with PCORI - New Priorities, Innovations, and an Update on Funding Opportunities to Advance Patient-Centered Comparative Clinical Effectiveness Research
2:30 PM - 2:45 PM
  • BREAK Gloucester (3rd Floor)
2:45 PM - 3:45 PM
  • CONTRIBUTED SESSION 13 Arlington-Clarendon (3rd Floor)
    Contributed Session 13: Pragmatic Trials (Moderated by: Kaleab Abebe)
      Are pragmatism and ethical protections in clinical trials a zero-sum game?
      Statistical Analysis Plan: Experiences within the Pain Management Collaboratory (PMC) projects
      Characteristics of VA Hospitals Participating in a Large Pragmatic Embedded Clinical Trial
      Using Patient-Reported Outcome Measures in Pragmatic Clinical Trials
  • CONTRIBUTED SESSION 14 Grand Salons HI (4th Floor)
    Contributed Session 14: Trial Design: Planning for Full-Scale Trials (Moderated by: Kendra Plourde)
      Intraclass Correlation Coefficients for Sample Size Calculations with Clustered Binary Outcomes
      Randomization procedures in parallel-arm cluster randomized trials in low- and middle-income countries:
      review of 300 trials published 2017-2022

      A Bayesian Design to Determine the Feasibility of Future Clinical Trials Given the Recruitment Rate Observed During a Pilot Study
      Exploring the usage of master protocols and seamless phase 2/3 trials in cardiovascular medicine - A case study on the COMPASS trial
  • CONTRIBUTED SESSION 15 Wellesley (3rd Floor)
    Contributed Session 15: Statistics: Reporting (Moderated by: Karla Hemming)
      Navigating Challenges in Communicating Interim Analysis to Non-Statisticians:
      Insights from Unblinded DMC Support Statisticians in Clinical Trials

      Increasing Efficiency in DSMB Report Generation Using R Markdown
      Interpretation of statistical findings in randomised trials: a survey of statisticians who work in clinical trials
      Interpretation of regression coefficients after data transformation: is it ever simple?
  • CONTRIBUTED SESSION 16 Grand Salons JK (4th Floor)
    Contributed Session 16: Data Coordination and Data Elements (Moderated by: Emily Rives)
      Medication Data Collection in Clinical Trials – Checklist vs. Log
      MoTrPAC Sample Processing: Automating Sample Management While Maintaining and Improving Quality Control.
      Enhancing Data Analysis in Clinical Trials: Utilizing Internal Use Only Forms for Comprehensive Data Capture in the TAPUR Study
      Site Report Cards for Performance in a Multicenter Trial of Exercise in Parkinsons Disease
  • CONTRIBUTED SESSION 17 Grand Salons FG (4th Floor)
    Contributed Session 17: Operations (Moderated by: Cory Goldstein)
      Challenges in Implementing Informed Consent Waivers for Acute Stroke Clinical Trials in Japan: Insights from Investigators’ Perspective
      Perspectives and Case Studies of Bioethicists and Patient Advocates on Data Monitoring Committees
      Simplified Research Consents: Harnessing ChatGPT for Enhanced Participant Understanding
      Underrepresentation of children with sickle cell disease in paediatric trials conducted in sub-Saharan Africa between 2010 and 2020:
      A Systematic Review
  • CONTRIBUTED SESSION 18 Suffolk (3rd Floor)
    Contributed Session 18: Data Sharing and Dissemination (Moderated by: Jody Ciolino)
      Unlocking untapped potential: How clinical trial sample registries can enable secondary research.
      Optimizing Research Dissemination: Managing Manuscripts, Presentations, and Abstracts in the U.S. POINTER Study
      Collaborative Process for Efficient Creation of Public Use and Investigator Datasets
      Harms Reporting in Randomized Trials Published Between 2018 and 2022
3:45 PM - 4:00 PM
  • BREAK
4:00 PM - 5:30 PM
  • INVITED SESSION 16 Grand Salons JK (4th Floor)
      Opportunities for Patient Centered Trial Design in Rare Disorders
  • INVITED SESSION 17 Wellesley (3rd Floor)
      Forecasting with Confidence: Harnessing Predictive Probabilities in Practice
  • INVITED SESSION 18 Grand Salons HI (4th Floor)
      Considerations in Community-Based Clinical Trials
  • INVITED SESSION 19 Suffolk (3rd Floor)
      A Centralized and Automated Process to Collaboratively Manage Action Item Follow up in Multi-Site Clinical Trials
  • INVITED SESSION 20 Grand Salons FG Foyer (4th Floor)
      JAMA Summit Update: Is the Clinical Trials Enterprise Broken? And How Can it be Fixed?
  • INVITED SESSION 21 Arlington-Clarendon (3rd Floor)
      Empowering Patient-Investigator-Industry Collaborations: The KISEKI Trial Story and Patient engagement in Japan and beyond.
Wednesday, May 22, 2024
7:30 AM - 12:00 PM
  • REGISTRATION Grand Ballroom Registration Desk (4th Floor)
8:00 AM - 8:15 AM
  • SPECIAL EVENT Grand Salons FG (4th Floor)
    Curtis Meinert Tribute
8:15 AM - 9:15 AM
  • CURTIS MEINERT KEYNOTE LECTURE Grand Salons FG (4th Floor)
    Accelerating Therapy Development in ALS and Other Neurological Disorders | Merit Cudkowicz, MD, MSC
9:30 AM - 10:30 AM
  • CONTRIBUTED SESSION 19 Arlington-Clarendon (3rd Floor)
    Contributed Session 19: Stepped-Wedge Cluster Randomized Trials (Moderated by: Ludovic Trinquart)
      Maintaining the validity of inference from linear mixed models in stepped-wedge cluster randomized trials under misspecified random-effects structures
      Designing Stepped Wedge Cluster Randomized Trials with Time-varying Treatment Effects under Non-uniform Correlation Structures
      Technical and Statistical Complexity when Designing a Stepped Wedge Randomised Controlled Trial Testing a Digital Health Intervention for Rheumatoid Arthritis, Embedded in Real World Practice (REMORA2)
      Exploring the effect of a stepped wedge staircase design using the STRATUS trial
  • CONTRIBUTED SESSION 20 Wellesley (3rd Floor)
    Contributed Session 20: Trial Design: General (Moderated by: Denise Esserman)
      Robust non-inferiority design in medical device clinical trial with non-concurrent historical control
      Statistical Properties of Restricted Randomization Designs with Finite Allocation Sequence Lengths
      Statistical Issues in Utilizing Electronic Health Records to Support Clinical Trial Design
      Novel trial designs in mental heath - results from a systematic review
  • CONTRIBUTED SESSION 21 Grand Salons JK (4th Floor)
    Contributed Session 21: Statistics: DOOR/Complex Outcomes (Moderated by: Fan Li)
      Beyond Intention-to-Treat: Win Ratio and Hierarchical Composite Cardiovascular Disease Outcomes in the VITAL and COSMOS Trials
      Connecting longitudinal desirability of outcome ranking (DOOR) analysis with multivariate survival outcomes
      Data Monitoring of Patient-Centric Benefit-Risk During a Clinical Trial Using Prediction and the Desirability of Outcome Ranking (DOOR) Methodology
      Bayesian Joint Modeling for Magnitude Endpoint with Intercurrent Events - Design and Analysis for LANDMARK II Trial
  • CONTRIBUTED SESSION 22 Grand Salons HI (4th Floor)
    Contributed Session 22: Recruitment (Moderated by: Yves Rosenberg)
      Recruiting Outside the Box: A Patient-Centered Approach within an Under-Researched Pediatric Down Syndrome Community
      Utilizing the Electronic Health Record and REDCap for Screening and Recruitment in Weight-Loss Trial
      Adapting to COVID-19: Digital Recruitment Strategies for ALS Clinical Trial Enrollment
      Rapid Enrollment in the MUSIC Study: Lessons Learned
  • CONTRIBUTED SESSION 23 Suffolk (3rd Floor)
    Contributed Session 23: Data Management: Technology (Moderated by: Logan Williams)
      The Devil is in the Detail: The Hidden Challenges of 3rd Party Tools in Clinical Trials
      Managing Participant Level Accounts in 3rd Party Apps - Challenges and Lessons Learned
      Expanding the Use of Artificial Intelligence While Protecting Data Privacy in Clinical Trials
      Assisting Clinical Sites with Electronic Medical Record (EMR) Study Builds to Support Timely Activation
  • CONTRIBUTED SESSION 24 Grand Salons FG (4th Floor)
    Contributed Session 24: Monitoring and Safety Reporting (Moderated by: Sejong Bae)
      Clarity in Safety Reporting vs. Data Entry Burden: Lessons Learned
      Uplifting the standard of monitoring in clinical trials – developing evidence and tools
      Novel Approaches for Clinical Trial Adverse Event Reporting with Implementation in R Shiny Web Applications
      Monitoring and Summarizing Safety Profile in Randomized Clinical Trials
10:30 AM - 10:45 AM
  • BREAK Grand Salons H-K & Suffolk (4th Floor & 3rd Floor)
10:45 AM - 12:15 PM
  • INVITED SESSION 22 Arlington-Clarendon (3rd Floor)
       Innovative Patient-Centered Trial Design Where Patients Can Receive Their Treatment Preference
  • INVITED SESSION 23 Wellesley (3rd Floor)
      Covariate-Adjustment in Randomized Trials
  • INVITED SESSION 24 Grand Salons FG (4th Floor)
      Enhancing community-based participation and engagement for patients, research personnel, and stakeholders on large network trials
  • INVITED SESSION 25 Suffolk (3rd Floor)
      Common Data Elements:
      Experiences from the NIH HEAL Initiative, the Effectiveness Research Network, the IMPOWR Network, and the Harm Reduction Research Network
  • INVITED SESSION 26 Grand Salons HI (4th Floor)
      The HEALEY ALS Platform Trial: Efficient Design and Implementation of new Regimens
  • INVITED SESSION 27 Grand Salons JK (4th Floor)
      Design and Analysis of Individually Randomized Group Treatment Trials

Faculty | Presenters

Frequently | Asked

Have a question? If you do not find the answer in our most frequently asked questions
below, please reach out to us at contact@sctweb.org.

The early registration deadline is Monday, March 25, 2024 (Midnight Central Standard Time).
Please click here to view the list of qualifying countries.
Discounted fees are only applicable to those who currently reside in one of the listed developing countries.
We request that all online registrations are paid for by credit card through the secure registration form.
All payments must be made in USD ($) to ensure that the full amount is received.
Credit cards are charged in real time at the time the registration is processed.
Yes. We accept Visa, MasterCard and American Express.

To request an Invitation Letter for the SCT Annual Meeting, please send a request to KellyBurns@sctweb.org after you have completed your registration and received a Meeting Confirmation/Receipt. The letter is subject to approval by office staff and will be sent to you by email.

You must be registered for the Annual Meeting to receive a letter.

Please note that is it your responsibility to check the Visa Entry Regulations into the USA. Further information can be found by clicking here.

If you have not received a receipt, please telephone (847) 427-8010 or email registration@sctweb.org.
No. All registrations are non-transferable. Any new attendee would need to register for the meeting on their own at the current registration rate..
Guest Registration is for the Networking Welcome Reception only. They are denied access to any and all educational sessions.
One-day or partial registrations are not available. Registration is for the entire meeting at the given rates.
All who are invited to participate in the program as Session Organizers, Session Chairs, Moderators, Presenters/Speakers, Discussants, Panelists, Oral/Poster Presenters, etc. are required to register for the meeting and pay all applicable fees, attend the meeting in-person to present, and make their own travel and housing arrangements paying all expenses on their own.
Attendees are not registering for roundtables, but rather indicating their topic of most interest. Please Note: your indicated preference does not guarantee you a seat at any roundtable as they will be available on a first come first serve basis.
No. You can indicate your preference for only one Roundtable Topic. We do recommend you have backup topics in mind in case your preferred topic is full at the meeting.
Yes. General meeting registration is required to indicate your roundtable topic of interest and attend any sessions.
The government rate is only applicable to those employed by the United States government.
To make changes to your housing reservation, you must contact the hotel directly.

Exhibition | Sponsors

If you are interested in becoming a Corporate Sponsor for our Annual Meeting, or for more information on the Sponsorship options available, please download the prospectus here or contact us at sponsorships@sctweb.org.

Thank You to Our 2023 Corporate Sponsors!

Gold Sponsor

BeiGene

BeiGene is a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines for far more patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through internal capabilities and collaborations. Our growing global team of more than 9000 colleagues spans five continents.

Gold Sponsor

Bristol Myers Squibb

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.

Gold Sponsor

Frontier Science Foundation

Frontier Science Foundation is a not-for-profit research organization dedicated to the improvement of data management and statistical quality in clinical trials and medical research.

Gold Sponsor

Merck & Co., Inc.

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.

Silver Sponsor

Amgen

Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything we do, we aim to fulfill our mission to serve patients. And every step of the way, we are guided by the values that define us.

Silver Sponsor

Berry Consultants

Berry Consultants is a statistical consulting company specializing in innovative clinical trial design, Bayesian analysis, adaptive clinical trial execution, and simulation software solutions for the pharmaceutical and medical device industry.

Silver Sponsor

GSK

Silver Sponsor

OneStudyTeam

OneStudyTeam, a member of the Reify Health portfolio, provides the cloud-based platform StudyTeam to accelerate the development of new therapies. StudyTeam brings research site workflows online and enables sites, sponsors, and other key stakeholders to work together effectively using common technology. One mission. One team. That’s OneStudyTeam.

Silver Sponsor

Otsuka

Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” In the U.S., Otsuka America Pharmaceutical, Inc. manufactures, markets, and distributes pharmaceuticals and medical devices in the challenging areas of neuroscience, nephrology, and digital health solutions.

Silver Sponsor

University of Wisconsin

The Data Coordinating Center (DCC) is a component of the Clinical Trials Program in the Department of Biostatistics and Medical Informatics at the UW School of Medicine and Public Health. The DCC supports investigator-initiated NIH or industry-sponsored RCTs. We provide expertise in planning, conduct, monitoring, and analysis of clinical trials.

Bronze Sponsor

StataCorp

Stata statistical software provides everything for your data science needs—data manipulation, visualization, statistics, and automated reporting. Whether you prefer a GUI, a command line, or scripts, Stata puts the statistics you want at your fingertips. Stata is easy to use and has your back with world-class support.

Bronze Sponsor

The Lotus Group

The Lotus Group LLC is a certified minority women-owned business (MWBE) delivering biometrics recruiting services nationally. We staff contract & permanent positions within the areas of Biostatistics, Clinical & Statistical Programming, Clinical Data Management, Data Science, Epidemiology, HEOR/RWE, and Pharmacometrics.